Walleye Capital LLC Horizon Therapeutics Public LTD CO Transaction History

Walleye Capital LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$96.34 - $112.38 $1.31 Million - $1.53 Million	-13,635 Reduced 23.23%	45,055 $4.63 Million
Q1 2023 May 15, 2023	BUY	$107.32 - $113.5 $1.62 Million - $1.72 Million	15,127 Added 34.72%	58,690 $6.41 Million
Q4 2022 Feb 14, 2023	BUY	$62.39 - $113.8 $2.72 Million - $4.96 Million	43,563 New	43,563 $4.96 Million
Q2 2022 Aug 08, 2022	BUY	$79.4 - $116.36 $4.93 Million - $7.22 Million	62,046 Added 846.58%	69,375 $5.53 Million
Q1 2022 May 16, 2022	SELL	$86.42 - $109.81 $214,408 - $272,438	-2,481 Reduced 25.29%	7,329 $771,000
Q4 2021 Mar 03, 2022	BUY	$98.56 - $119.91 $966,873 - $1.18 Million	9,810 New	9,810 $1.06 Million
Q1 2020 May 15, 2020	SELL	$24.87 - $38.56 $51,132 - $79,279	-2,056 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$25.43 - $36.67 $3,661 - $5,280	-144 Reduced 6.55%	2,056 $74,000
Q3 2019 Nov 14, 2019	BUY	$23.0 - $27.97 $25,300 - $30,767	1,100 Added 100.0%	2,200 $60,000
Q2 2019 Aug 14, 2019	BUY	$22.81 - $28.48 $25,091 - $31,328	1,100 New	1,100 $26,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.